Company intelligence / Profile preview

KangDuo Robotics

Harbin, Heilongjiang, Chinakangduorobot.com ↗

Ownership: Private
Development stage: Other

Overview

KangDuo Robotics' core product—the KANGDUO® SR2000/KD-SR series—has been approved by the Chinese NMPA as a Class III medical device for endoscopic/laparoscopic procedures. Clinical studies show feasibility and safety in urologic oncology with high accuracy and low complication rates. The system has performed over 100 operations at single hospitals and supports advanced features like dual-surgeon consoles and remote operation via high-speed networks.

Therapeutic areas: Men's HealthWomen's HealthOther
Modalities: Device (Surgical robot)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on KangDuo Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KangDuo Robotics.

Explore the full profile